Answer
Yes. It is licensed with fluorouracil and leucovorin after metastatic pancreatic cancer has progressed following gemcitabine-based therapy.
Sources for this answer
- ONIVYDE pegylated liposomal 4.3 mg/ml concentrate for dispersion for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.